Cancer Prevention News

SEATTLE — Just 1 year after quitting smoking, people with HIV face roughly the same risk of acquiring most cancers as those with the virus who had never smoked, according to a study.

This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results.

Negative changes in menopause-specific quality of life can influence a woman’s choice to end breast cancer chemoprevention therapy, according to study data published in the Journal of Clinical Oncology.

Pregnant women who have undergone prior surgical treatment for cervical dysplasia demonstrated an increased risk for preterm birth and low birth weight compared with women with no history of cervical diagnostic or treatment procedures, or women with a history of diagnostic procedures but no treatment, according to a population-based, observational study published in PLOS ONE.

Smokers who undergo lung cancer screening and receive both cessation resources and telephone counseling are more likely to quit than those who receive cessation resources only, according to a study recently published in Lung Cancer.

Women who received a false-positive mammogram result were more likely to put off getting future screening, according to research recently released in Cancer Epidemiology, Biomarkers and Prevention.  

National Cancer Prevention Month, established by a U.S. Senate resolution and observed every February since 2004, is intended to draw attention to the fact that approximately 70% of malignancies may be prevented through diet or other lifestyle changes.

Jeff Vacirca, MD, FACP, CEO and managing director of clinical research at New York Cancer Specialists in Long Island, N.Y., has been elected president of Community Oncology Alliance for the 2017-2018 term.

Physicians’ willingness to communicate with patients about the cost of cancer care appeared associated with improved patient satisfaction and lower out-of-pocket expenses.

Many women with newly diagnosed breast cancer are not receiving the genetic testing that could detect mutations associated with ovarian and other cancers, according to a large survey published in JAMA.